INmune Bio, Inc.

NASDAQ:INMB

5.19 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Omzet 00.0140.0280.0430.0460.0380.0970.0980.0160.1630.1630.01400.0040.01100077.6880000000000000
Kosten van de omzet 00000000000000000000000000000000
Brutowinst 00.0140.0280.0430.0460.0380.0970.0980.0160.1630.1630.01400.0040.01100077.6880000000000000
Brutowinstmarge 01111111111101100010000000000000
Onderzoek- en ontwikkelingskosten 7.0538.6936.0075.9854.1484.1333.415.1594.1894.3097.0686.524.4642.4911.8592.3630.9030.7930.8671.1680.2940.1020.5150.1990.2870.1040.2680.0460.0650.0580.0280.028
Algemene en administratieve kosten 2.8122.3382.42.5862.3092.3282.3292.3822.2152.3322.1252.5152.092.0611.3612.4561.2041.2991.4661.9161.6771.8091.3651.3415.8872.7420.160.2610.10.0620.0570.027
Verkoop- en marketingkosten 0.0410000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 2.8122.3382.42.5862.3092.3282.3292.3822.2152.3322.1252.5152.092.0611.3612.4561.2041.2991.4661.9161.6771.8091.3651.3415.8872.7420.160.2610.10.0620.0570.027
Overige kosten 0.119-0.008-0.029-0.035-0.09-0.113-0.191-0.282-0.45-0.425-0.641-0.437-0.101-0.0080.0050.102-00.02200.0170.0360.010000000000
Bedrijfskosten 9.86511.0318.4078.5716.4576.4615.7397.5416.4046.6419.1939.0356.5544.5523.224.8192.1072.0922.3323.0841.971.9111.881.546.1742.8460.4280.3080.1650.0310.1350.054
Bedrijfsresultaat -9.865-11.017-8.379-8.528-6.411-6.423-5.642-7.443-6.388-6.478-9.03-9.021-6.554-4.548-3.209-4.819-2.107-2.092-2.332-3.084-0.428-1.911-1.88-1.54-6.174-2.846-0.428-0.308-0.165-0.119-0.085-0.054
Bedrijfsresultaat ratio 0-786.929-299.25-198.326-139.37-169.026-58.165-75.949-399.25-39.742-55.399-644.3570-1,137-293.959000-0.030000000000000
Totaal overige inkomsten en kosten netto 0.119-0.008-0.029-0.035-0.09-0.113-0.191-0.282-0.45-0.425-0.641-0.437-0.101-0.0080.0050.102-00.0220.0140.0171.5420.01-12,440.023000-0000.15-0.050
Inkomen voor belasting -9.746-11.025-8.408-8.563-6.501-6.536-5.833-7.725-6.838-6.903-9.671-9.458-6.655-4.556-3.204-4.717-2.108-2.07-2.318-3.067-0.392-1.901-1.88-1.54-6.174-2.846-0.428-0.308-0.1650.031-0.135-0.054
Inkomen voor belasting ratio 0-787.5-300.286-199.14-141.326-172-60.134-78.827-427.375-42.35-59.331-675.5710-1,139-293.54000-0.030000000000000
Belastingkosten -9.865-11.01714.826-8.528-6.4110.1130.1910.2820.450.42521.31-9.021-6.554-4.548-3.209-4.82-2.107-2.092-2.332-3.0841.506-1.911-12,441.903-1.54-6.174-2.846-0.428-0.30800.15-0.050
Nettowinst -9.746-11.025-8.408-8.563-6.501-6.649-6.024-8.007-7.288-7.328-9.671-9.458-6.655-4.556-3.204-4.717-2.108-2.07-2.318-3.067-0.392-1.901-1.88-1.54-6.174-2.846-0.428-0.308-0.1650.031-0.135-0.054
Nettowinstmarge 0-787.5-300.286-199.14-141.326-174.974-62.103-81.704-455.5-44.957-59.331-675.5710-1,139-293.54000-0.030000000000000
WPA (Winst Per Aandeel) -0.5-0.61-0.47-0.48-0.36-0.37-0.34-0.45-0.41-0.41-0.56-0.55-0.44-0.32-0.25-0.36-0.2-0.19-0.22-0.28-0.039-0.2-0.17-0.14-0.55-0.25-0.038-0.027-0.0280.006-0.027-0.011
Verwaterde WPA -0.5-0.61-0.47-0.48-0.36-0.37-0.34-0.45-0.41-0.41-0.56-0.55-0.44-0.32-0.25-0.36-0.2-0.19-0.22-0.28-0.039-0.2-0.17-0.14-0.55-0.25-0.038-0.027-0.0280.006-0.027-0.011
EBITDA -9.865-11.017-8.379-8.528-6.411-6.423-5.642-7.443-6.388-6.478-9.03-9.021-6.554-4.548-3.209-4.819-2.107-2.092-2.332-3.084-3.512-1.911-1.88-1.54-6.174-2.846-0.428-0.30800.15-0.050
EBITDA ratio 0-786.929-299.25-198.326-139.37-169.026-58.165-75.949-399.25-39.742-55.399-644.3570-1,137-293.959000-0.030000000000000